Dose de-escalation strategies and role of therapeutic drug monitoring of biologics in RA

Rheumatology (Oxford). 2010 Oct;49(10):1801-3. doi: 10.1093/rheumatology/keq060. Epub 2010 Mar 23.

Authors

Alfons A den Broeder, Aatke van der Maas, Bart J F van den Bemt

PMID: 20332095
DOI: 10.1093/rheumatology/keq060

No abstract available

Publication types

Editorial

MeSH terms

Antirheumatic Agents / administration & dosage*
Antirheumatic Agents / economics
Arthritis, Rheumatoid / drug therapy*
Biological Products / economics
Biological Products / therapeutic use*
Dose-Response Relationship, Drug
Drug Administration Schedule
Drug Monitoring
Humans
Randomized Controlled Trials as Topic
Treatment Outcome

Substances

Antirheumatic Agents
Biological Products